Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.

Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the United Kingdom. The company is launching its Hers platform to provide ...

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

LONDON--(BUSINESS WIRE)--Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction ...

LONDON--(BUSINESS WIRE)-- Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official ...

Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction of the Hers platform, ...

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss ...

Hims stock surged more than 40% Monday morning on news that Novo Nordisk will distribute its weight-loss drugs through the ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform ...

Shares in Wegovy and Ozempic maker Novo Nordisk rose after Hims & Hers said it would not offer a copycat version of the Danish drugmaker's weight-loss pill. In afternoon European trade, shares were up ...